Contemporary Management of Complex Skin Cancers 2024


Contemporary Management of Complex Skin Cancers 2024 Banner

Add to Calendar Contemporary Management of Complex Skin Cancers 2024 11/1/2024 8:00:00 AM 11/2/2024 4:15:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=49152 Description: This unique course delivers cutting-edge updates on the multidisciplinary approaches to managing complex skin cancers, including high-risk squamous cell carcinoma, Merkel cell carcinoma, and melanoma. Advances in complex skin malignancies will be presented and discussed in a collaborative tumor board format, featuring a distinguished panel of Memorial Sloan Kettering Cancer Center experts from Mohs and... Zuckerman Research Center false MM/DD/YYYY


Date & Location
Friday, November 1, 2024, 8:00 AM - Saturday, November 2, 2024, 4:15 PM, Zuckerman Research Center, New York, NY

Specialties
Specialties - Dermatology, ENT, Head and Neck Oncology, Head and Neck Surgery, Immunotherapy, Ophthalmic Surgery, Ophthalmology, Pathology, Physician Assistant, Plastic and Maxillofacial Surgery, Plastic Surgery, Radiation Oncology, Surgical Oncology, Urology

Overview

This unique course delivers cutting-edge updates on the multidisciplinary approaches to managing complex skin cancers, including high-risk squamous cell carcinoma, Merkel cell carcinoma, and melanoma. Advances in complex skin malignancies will be presented and discussed in a collaborative tumor board format, featuring a distinguished panel of Memorial Sloan Kettering Cancer Center experts from Mohs and Dermatologic Surgery, Head and Neck Surgery, Medical, Surgical, and Ophthalmic Oncology, Pathology, and Radiation Oncology. With a focus on novel diagnostic methods and updates in tumor classification, attendees will gain valuable insights into the contemporary practices that are shaping the field.

This year’s program will encompass:

  • Recent advances in Squamous Cell Carcinoma, including developments in staging, neoadjuvant, and innovative treatment modalities.
  • Multidisciplinary case-based discussion on hereditary cancer syndromes, including Lynch and Gorlin.
  • Update on Merkel Cell Carcinoma including the latest breakthroughs and insights.
  • New case-based session focused on Mohs tissue processing for eyelid, nail, ear skin malignancies and reconstruction techniques
  • Pearls and advances in modern approaches, addressing prevention, wound healing, scar revision, and noninvasive imaging.
  • Recent advances and hot topics in the management and treatment of melanoma, including neoadjuvant and TIL therapy.
  • Key sessions will culminate in a multidisciplinary tumor board, encouraging active participation and questions from attendees.

Ample time will be provided for networking during breaks and fostering professional collaborations among attendees and our esteemed faculty members. As this course is ideally suited for an in-person format, a virtual option will not be available.

The course is intended for physicians and allied health professionals, who care for patients with skin cancer, including dermatologists, surgical and medical oncologists, otolaryngologists, ophthalmologists, general surgeons, plastic surgeons, pathologists, and radiation oncologists.

Objectives
At the conclusion of this course, attendees will be able to:

  1. Describe melanoma and non melanoma skin cancer incidence and staging systems
  2. Define characteristics of skin cancers that require multidisciplinary treatment
  3. Assess role and variety of radio-therapeutic approaches to complex skin cancer
  4. Review role of biological therapy in the treatment of advanced skin cancer
  5. Review novel approaches to optimize surgical treatment of skin cancers

Registration

Included in registration, attendees will be offered continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations for joining us onsite.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Registration Rates

  • Physicians (MDs, PhDs, and DOs): $495
  • Advanced Practice Providers: $395
  • Residents, Fellows, Nurses, and Other Healthcare Providers: $200
  • Industry Professionals*: $875
  • MSK Employees: Complimentary

For details on our cancellation terms, please review our Cancellation Policy.

*An “industry professional” is defined as any individual, regardless of their profession type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 13.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and
  • 13.25 Part II Self-Assessment points in the American Board of Otolaryngology-Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program; and
  • 13.25 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification (CC) program; and
  • 13.25 CME and Self-Assessment requirements of the American Board of Surgery’s (ABS) Continuous Certification (CC) program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation. MOC/CC points earned will be reported to the board within 45 days of completing the post-course evaluation.